BeStock  
Stocks › Biotechnology › ATTO

Attovia Therapeutics ATTO

US equityMarket cap rank #3395Biotechnology
$15.10 −$0.48 (-3.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $15.10 0.00%
Open$15.40
Prev close$15.58
Day range$14.80 – $15.46
Volume372.2K
Market cap$690.26M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

ATTO at a glance

Attovia Therapeutics stock (ATTO) sits at $15.10, down 3.08% today. The business is worth $690.26M in the market, good for #3395 of 3753 on our coverage list.

Over the past 52 weeks it has traded between $12.94 and $28.00, so it sits 46.1% below the top of that range.

In the quarter ended Sep 2026 the company brought in $0.00 of revenue, down 100.0% from a year earlier, and a net loss of $22.27M.

4 analysts follow the stock and the average call is "buy". The mean target, $41.00, sits 171.5% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$14.10 / $19.53
Average price today$15.08
Volume372.2K
Turnover$5.61M
Turnover rate2.19%of shares outstanding
Volume ratio1.45vs. recent average pace
Day amplitude4.22%
Market cap$690.26M
Float market cap$256.70M
Shares outstanding17.00M
EPS (TTM)-$1.42
P/B1.74
Book value / share$8.70
Net profit (TTM)-$64.68M
Net assets$397.74M
30-day volatility62.6%annualized
Avg daily range (ATR)9.37%of price, 14 days
Max drawdown (1y)-46.3%-40.9% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

4 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 27.7 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth23.1
Profitability18.1
Momentum14.2
Financial health86.9
Analyst view95.6

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$41.00+171.5% vs. current price
Consensus ratingBuy4 analysts covering
Morningstar fair value$18.31Price is below fair value

Wall Street’s average 12-month target is $41.00, 171.5% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $18.31, so shares trade 17.5% below that estimate. On earnings multiple, it sits in the 94th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-3.1%
1 week
-0.2%
1 month
+4.1%
3 months
-26.8%
Day range
$14.80$15.46
52-week range
$12.94$28.00

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 4 bearish of 5 signals

IndicatorValueSignal
Price vs 20-day average-1.8%Bearish
Price vs 50-day average-9.6%Bearish
RSI (14)45.2Bearish
MACD (12,26,9)-0.25Bullish
Bollinger band position39%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How ATTO ranks on BeStock

Market value#3378 of 3734
Closeness to 52-week high#2890 of 3724
Dollar volume today#2649 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

ATTO is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on ATTO.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on ATTO

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

ATTO stock: common questions

What is ATTO's latest share price?

$15.10 is the latest print for ATTO, a move of -3.08% against yesterday's close of $15.58. Today's low and high so far: $14.80 and $15.46.

How big is Attovia Therapeutics?

Equity value comes to $690.26M at the current price. By that measure it is number 3395 of the 3753 names in our coverage.

Where does ATTO sit in its 52-week range?

The year's floor is $12.94 and the ceiling $28.00. Shares are 46.1% away from that ceiling.

Does ATTO send cash back through a dividend?

Our data shows no dividend paid by Attovia Therapeutics over the trailing twelve months.

Do Wall Street analysts like ATTO?

Of 4 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $41.00, with the most cautious at $34.00 and the most optimistic at $45.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on ATTO.

Sign in to join the discussion.

Scroll to Top